Betta Pharmaceuticals Co., Ltd. (300558.SZ) SHZ
Currency In CNY
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
AD
Currency In CNY
| Market Cap | 19.53B |
| Enterprise Value | 20.63B |
| P/E Ratio | 55.92 |
| PEG Ratio | 6.78 |
| Price/Sales Ratio | 6.6 |
| Price/Book Ratio | 3.63 |
| Enterprise/Revenue | 7.17 |
| Enterprise/EBITDA | 25.47 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | March 31, 2026 |
| Profit Margin | 0.12 |
| Operating Margin | 0.15 |
| Return On Assets | 0.04 |
| Return On Equity | 0.07 |
| Revenue | 3.61B |
| Revenue/Share | 8.86 |
| Gross Profit | 2.87B |
| EBITDA | 1.04B |
| Net Income | 305.33M |
| Diluted EPS | 0.73 |
| Total Cash | 510.23M |
| Total Cash/Share | 1.21 |
| Total Debt | 2.56B |
| Total Debt/Equity | 0.38 |
| Current Ratio | 0.99 |
| Book Value Per Share | 16.29 |
| 52-Week Change | 6.53 |
| 52-Week High | 79.8 |
| 52-Week Low | 40.1 |
| Moving Average 50 Days | 49.47 |
| Moving Average 200 Days | 50.98 |
| Average Volume | 12.56M |
| Shares Outstanding | 420.73M |
| % Held by Institutions | N/A |
| Trailing Annual Dividend Rate | 0.15 |
| Trailing Annual Dividend Yield | 0.26 |
| Payout Ratio | 0.3 |
| Last Split Factor | N/A |
| Last Split Date | N/A |